Root Admin Guide Posted March 24, 2014 Root Admin Report Share Posted March 24, 2014 Monthly Prescribing Reference (MPR) announced, "Positive Results Announced for Rosacea Treatment" from two "randomized, double-blind, 12-week vehicle controlled parallel–group studies assessing the efficacy and safety of ivermectin 1% cream in subjects with papulopustular rosacea." Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now